Index
- Early Observations: Dr. Norio Niikawa’s Insight
- Japan Dysmorphology Conferences: Collaboration with Dr. Kuroki
- The Naming of Kabuki Syndrome: A Cultural Homage
- Global Recognition and Genetic Discoveries
- Professor Norio Niikawa: A Remarkable Life and Legacy
- Kabuki Syndrome Today: Neurological and Cultural Legacy
Kabuki syndrome, characterized by distinctive facial features, developmental delays, and multisystem involvement, offers child neurologists a remarkable intersection of clinical genetics, pediatric neurology, and cultural history. Its historical narrative, enriched with personal anecdotes, begins with meticulous clinical observation and profound cultural resonance.

Early Observations: Dr. Norio Niikawa’s Insight
In 1969, Professor Norio Niikawa, then a young geneticist at Hokkaido University in Japan, encountered a young girl with unique facial characteristics and multiple health issues. Having never seen such a constellation of symptoms before, Niikawa suspected he might be witnessing an undiscovered genetic condition. Uncertain of a diagnosis, her clinical data sat in a file for 10 years. Over subsequent years, he documented four more cases with strikingly similar clinical presentations in his outpatient genetics clinic, strengthening his hypothesis.
Japan Dysmorphology Conferences: Collaboration with Dr. Kuroki
In 1979, Professor Niikawa presented his findings at the first Japan Dysmorphology Conference. At this seminal meeting, Dr. Yoshikazu Kuroki, a pediatrician from Kyushu, immediately recognized the symptoms described by Niikawa, realizing he had independently encountered similar cases. Kuroki presented two of his own patients at the second annual conference in 1980, cementing recognition of this new clinical entity.
In 1981, both physicians separately submitted landmark articles to the Journal of Pediatrics, officially introducing Kabuki syndrome to international medicine. Due to this concurrent discovery, the condition is also known as Niikawa–Kuroki syndrome.
The Naming of Kabuki Syndrome: A Cultural Homage
Professor Niikawa coined the term "Kabuki syndrome" (also known as Kabuki make-up syndrome) to honor traditional Japanese Kabuki theatre. The distinctive elongated palpebral fissures and eversion of lower eyelids seen in patients reminded him vividly of the dramatic makeup ("kumadori") applied by Kabuki actors.
"The name 'Kabuki make-up' of the syndrome was given by myself because the facial appearance of patients, especially the eversion of their lower eyelids, is reminiscent of the makeup of actors in Kabuki, the traditional form of Japanese theatre. Kabuki was founded early in the 17th century and developed into a sophisticated art form. Kabuki actors apply makeup to emphasize their eyes, particularly in heroic roles, and they are proud of their performing art."
Global Recognition and Genetic Discoveries
After initial clinical descriptions, Kabuki syndrome gained international recognition. In 2010, Professor Niikawa, collaborating with international researchers, contributed significantly to the discovery of pathogenic mutations in the KMT2D (MLL2) gene. This breakthrough established Kabuki syndrome as an epigenetic disorder, revolutionizing diagnostic and management strategies.
Professor Norio Niikawa: A Remarkable Life and Legacy
Professor Niikawa (1942–2022), Emeritus Professor of Nagasaki University and former President of the Health Sciences University of Hokkaido, was renowned internationally not only for his discovery of Kabuki syndrome but for many seminal contributions to human genetics. After graduating from Hokkaido University School of Medicine in 1967, he pursued advanced chromosome research under Professor Sajiro Makino at Hokkaido University and later with Dr. Tadashi Kajii in Geneva, Switzerland. His groundbreaking research included the origins of chromosomal anomalies, imprinting disorders (Angelman and Prader-Willi syndromes), and identifying genes for Mendelian diseases like Waardenburg syndrome, Sotos syndrome, Marfan syndrome type II, Camurati-Engelmann disease, and even the genetic determinants of earwax.
Professor Niikawa passed away peacefully on 4 April 2022, at age 79, leaving behind a profound legacy in human genetics. His former student Naomichi Matsumoto from Yokohama City University Graduate School of Medicine remembered him warmly:
"When I was a graduate student in his laboratory, we had hot long evening discussions about how to proceed with his ongoing role-playing video games. Although our working environment was modest, those years under his guidance were some of my happiest times as a researcher. Professor Niikawa’s words were wise and frequently prophetic. His passing is a huge loss to the global genetics community. Professor Niikawa, may your soul rest joyfully in peace—perhaps now you can relax with your favorite cigarette in heaven. Our hands join in prayerful gratitude."
Kabuki Syndrome Today: Neurological and Cultural Legacy
Today, Kabuki syndrome represents far more than its clinical features. It symbolizes the enduring legacy of a visionary scientist whose keen observations and cultural mindfulness enriched pediatric neurology and human genetics. Child neurologists caring for Kabuki syndrome patients continue Professor Niikawa’s legacy through compassionate care, scientific curiosity, and multidisciplinary collaboration.
In essence, Kabuki syndrome’s history—from a single clinical observation by a dedicated young pediatrician in 1969 to an international genetic breakthrough—remains a testament to the power of detailed clinical observation, passionate scientific inquiry, and deep cultural appreciation, all qualities embodied in the remarkable life of Professor Norio Niikawa.
Cover image: Kabuki Actor Ichikawa Ebizō V as Kumagai Jirō Naozane (ca. 1849): Utagawa Kunimasu